Woodmont Investment Counsel’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Woodmont Investment Counsel’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,000	Closed	-$203K	–	192
2017 Q3	$203K	Hold	2,000	–	–	0.06%	180
2017 Q2	$201K	Buy	+2,000	New	+$215K	0.06%	175
2016 Q4	–	Sell	-100	Closed	-$13K	–	677
2016 Q3	$13K	Buy	+100	New	+$9.56K	﹤0.01%	435
2016 Q2	–	Sell	-200	Closed	-$14K	–	489
2016 Q1	$14K	Hold	200	–	–	﹤0.01%	387
2015 Q4	$14K	Hold	200	–	–	﹤0.01%	396
2015 Q3	$18K	Buy	200 +100	+100%	+$11.1K	0.01%	358
2015 Q2	$12K	Buy	+100	New	+$11.3K	﹤0.01%	415

Other funds holding GWPH

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Woodmont Investment Counsel's GWPH Position: Q4 2017 in Review

Woodmont Investment Counsel sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 2,000 shares — an estimated $203K sold.

Woodmont Investment Counsel first reported a position in GWPH in Q2 2015 and held it in 7 quarters. The position peaked at $203K in Q3 2017. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

Woodmont Investment Counsel reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
Woodmont Investment Counsel sold 2,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $203K.
Woodmont Investment Counsel first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2015 and held it in 7 quarters.
Woodmont Investment Counsel's GW Pharmaceuticals Plc American Depositary Shares position peaked at $203K in Q3 2017.
204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Woodmont Investment Counsel's 13F filing for Q4 2017, filed 13 Feb 2018.